OBJECTIVE: We investigated the prognostic value of preoperative neutrophil-to-lymphocyte ratio (NLR) on germ cell testicular tumors (GCT). MATERIAL AND METHODS: The data of 53 patients who underwent inguinal orchiectomy were analyzed retrospectively. NLR was calculated from the preoperative complete blood cell counts. Receiver operating characteristic (ROC) analysis was performed to find the threshold values for NLR. Correlations between cancer-specific survival (CSS) and progression-free survival (PFS) and NLR were evaluated. RESULTS: The mean follow-up time was 23.55±18.06 months. The mean level of NLR was 3.08±1.81. Optimal threshold values of NLR was calculated as 3.55 for PFS (area under curve, AUC: 0.55) and 3.0 for CSS (AUC: 0.66). For patients with a NLR of <3.55 and NLR of ≥3.55, mean times-to-progression were 55.71 months (95% CI, 51.27-60.14) and 51.95 months (95% CI, 38.02-65.87, p=0.152), respectively. As well as, for patients with a NLR of <3.0 and NLR of ≥3.0, mean times-to-cancer specific death were 54.72 months (95% CI, 49.05-60.38) and 49.43 months (95% CI, 37.64-61.22, p=0.119), respectively. CONCLUSION: Preoperative NLR is not a useful tool to predict the prognosis of patients with GCT.
OBJECTIVE: We investigated the prognostic value of preoperative neutrophil-to-lymphocyte ratio (NLR) on germ cell testicular tumors (GCT). MATERIAL AND METHODS: The data of 53 patients who underwent inguinal orchiectomy were analyzed retrospectively. NLR was calculated from the preoperative complete blood cell counts. Receiver operating characteristic (ROC) analysis was performed to find the threshold values for NLR. Correlations between cancer-specific survival (CSS) and progression-free survival (PFS) and NLR were evaluated. RESULTS: The mean follow-up time was 23.55±18.06 months. The mean level of NLR was 3.08±1.81. Optimal threshold values of NLR was calculated as 3.55 for PFS (area under curve, AUC: 0.55) and 3.0 for CSS (AUC: 0.66). For patients with a NLR of <3.55 and NLR of ≥3.55, mean times-to-progression were 55.71 months (95% CI, 51.27-60.14) and 51.95 months (95% CI, 38.02-65.87, p=0.152), respectively. As well as, for patients with a NLR of <3.0 and NLR of ≥3.0, mean times-to-cancer specific death were 54.72 months (95% CI, 49.05-60.38) and 49.43 months (95% CI, 37.64-61.22, p=0.119), respectively. CONCLUSION: Preoperative NLR is not a useful tool to predict the prognosis of patients with GCT.
Entities:
Keywords:
Inflammation; neutrophil-lymphocyte ratio; prognosis; survival; testicular cancer
Authors: K Shafique; M J Proctor; D C McMillan; K Qureshi; H Leung; D S Morrison Journal: Prostate Cancer Prostatic Dis Date: 2011-11-29 Impact factor: 5.554
Authors: E Jabłońska; M Kiluk; W Markiewicz; L Piotrowski; Z Grabowska; J Jabłoński Journal: Arch Immunol Ther Exp (Warsz) Date: 2001 Impact factor: 4.291
Authors: Sara Bleve; Maria Concetta Cursano; Chiara Casadei; Giuseppe Schepisi; Cecilia Menna; Milena Urbini; Caterina Gianni; Silvia De Padova; Alessia Filograna; Valentina Gallà; Giovanni Rosti; Domenico Barone; Michal Chovanec; Michal Mego; Ugo De Giorgi Journal: Front Oncol Date: 2022-06-10 Impact factor: 5.738
Authors: Samira Hosseini; Sarah C Moody; Daniela Fietz; Sivanjah Indumathy; Hans-Christian Schuppe; Mark P Hedger; Kate L Loveland Journal: Histochem Cell Biol Date: 2022-07-12 Impact factor: 2.531
Authors: Michal Chovanec; Zuzana Cierna; Viera Miskovska; Katarina Machalekova; Katarina Kalavska; Katarina Rejlekova; Daniela Svetlovska; Dusan Macak; Stanislav Spanik; Karol Kajo; Pavel Babal; Ugo De Giorgi; Michal Mego; Jozef Mardiak Journal: Br J Cancer Date: 2018-02-27 Impact factor: 7.640
Authors: Domen Ribnikar; Igor Stukalin; Philippe L Bedard; Robert J Hamilton; Michael Jewett; Padraig Warde; Peter Chung; Lynn Anson-Cartwright; Arnoud J Templeton; Eitan Amir; Aaron R Hansen; Daniel Y C Heng; Jeremy Lewin Journal: Curr Oncol Date: 2020-12-21 Impact factor: 3.677